© 2021 Bayer Ltd

This website contains information on Xarelto (rivaroxaban) which is based on the Summary of Product Characteristics (SmPC) as approved by the European Commission. It is intended to provide information to an international audience outside the USA.

PP-XAR-IE-0739-3

Last updated on 26/05/2023